Ruben Mesa/vjhemonc.com
Jun 16, 2025, 02:02
Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:
“Honored to have been the senior author of this Plenary Abstract at EHA25 (presented by great colleague Harry Gill, The University of Hong Kong ) of the Phase III SURPASS ET trials showing Superiority of ROPEG over ANAGRELIDE in 2L for Essential Thrombocythemia”
More posts featuring EHA 2025.
-
Mar 13, 2026, 10:28Anupama Ariyasiri։ A Systematic Review of Transfusion Strategies in Neurocritical Care
-
Mar 13, 2026, 10:08Jack Hadfield: An Important Step Toward Finding Measurable Biology in Long COVID
-
Mar 13, 2026, 10:00Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis